JP2008521874A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008521874A5 JP2008521874A5 JP2007543935A JP2007543935A JP2008521874A5 JP 2008521874 A5 JP2008521874 A5 JP 2008521874A5 JP 2007543935 A JP2007543935 A JP 2007543935A JP 2007543935 A JP2007543935 A JP 2007543935A JP 2008521874 A5 JP2008521874 A5 JP 2008521874A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- formula
- compound
- alkoxy
- hcl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 125000000217 alkyl group Chemical group 0.000 claims 33
- 150000001875 compounds Chemical class 0.000 claims 27
- 238000000034 method Methods 0.000 claims 12
- 150000003839 salts Chemical class 0.000 claims 9
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 claims 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 8
- 125000003545 alkoxy group Chemical group 0.000 claims 8
- 239000008194 pharmaceutical composition Substances 0.000 claims 8
- 239000002253 acid Substances 0.000 claims 7
- 125000000623 heterocyclic group Chemical group 0.000 claims 7
- 238000002360 preparation method Methods 0.000 claims 7
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 6
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 4
- 229910052757 nitrogen Inorganic materials 0.000 claims 4
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims 3
- 229910052799 carbon Inorganic materials 0.000 claims 3
- 125000004432 carbon atom Chemical group C* 0.000 claims 3
- 125000004093 cyano group Chemical group *C#N 0.000 claims 3
- 229910052736 halogen Inorganic materials 0.000 claims 3
- 150000002367 halogens Chemical class 0.000 claims 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 3
- 230000002265 prevention Effects 0.000 claims 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 2
- 125000003118 aryl group Chemical group 0.000 claims 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 2
- 239000007795 chemical reaction product Substances 0.000 claims 2
- 206010012601 diabetes mellitus Diseases 0.000 claims 2
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 claims 2
- -1 hydroxy, fluoromethyl Chemical group 0.000 claims 2
- 201000001421 hyperglycemia Diseases 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 239000000047 product Substances 0.000 claims 2
- 239000002904 solvent Substances 0.000 claims 2
- 125000001424 substituent group Chemical group 0.000 claims 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 2
- 201000001320 Atherosclerosis Diseases 0.000 claims 1
- 208000002705 Glucose Intolerance Diseases 0.000 claims 1
- 206010018429 Glucose tolerance impaired Diseases 0.000 claims 1
- 208000035150 Hypercholesterolemia Diseases 0.000 claims 1
- 206010060378 Hyperinsulinaemia Diseases 0.000 claims 1
- 208000031226 Hyperlipidaemia Diseases 0.000 claims 1
- 238000002441 X-ray diffraction Methods 0.000 claims 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 230000005961 cardioprotection Effects 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 claims 1
- 125000001072 heteroaryl group Chemical group 0.000 claims 1
- 125000005842 heteroatom Chemical group 0.000 claims 1
- DKAGJZJALZXOOV-UHFFFAOYSA-N hydrate;hydrochloride Chemical compound O.Cl DKAGJZJALZXOOV-UHFFFAOYSA-N 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 1
- 230000003451 hyperinsulinaemic effect Effects 0.000 claims 1
- 201000008980 hyperinsulinism Diseases 0.000 claims 1
- 208000031225 myocardial ischemia Diseases 0.000 claims 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 1
- 201000009104 prediabetes syndrome Diseases 0.000 claims 1
- 238000001953 recrystallisation Methods 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63246304P | 2004-12-02 | 2004-12-02 | |
| PCT/GB2005/050234 WO2006059165A1 (en) | 2004-12-02 | 2005-12-02 | Pyrrolopyridine-2-carboxylic acid amide derivative useful as inhibitor of glycogen phosphorylase |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008521874A JP2008521874A (ja) | 2008-06-26 |
| JP2008521874A5 true JP2008521874A5 (enExample) | 2008-12-04 |
Family
ID=35735250
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007543935A Withdrawn JP2008521874A (ja) | 2004-12-02 | 2005-12-02 | グリコーゲンホスホリラーゼのインヒビターとして有用なピロロピリジン−２−カルボン酸アミド誘導体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8664397B2 (enExample) |
| EP (1) | EP1819704B1 (enExample) |
| JP (1) | JP2008521874A (enExample) |
| AT (1) | ATE400574T1 (enExample) |
| DE (1) | DE602005008099D1 (enExample) |
| DK (1) | DK1819704T3 (enExample) |
| ES (1) | ES2309822T3 (enExample) |
| PL (1) | PL1819704T3 (enExample) |
| PT (1) | PT1819704E (enExample) |
| WO (1) | WO2006059165A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20110235A1 (es) | 2006-05-04 | 2011-04-14 | Boehringer Ingelheim Int | Combinaciones farmaceuticas que comprenden linagliptina y metmorfina |
| EP2394647A1 (en) | 2006-11-02 | 2011-12-14 | Aestus Therapeutics, Inc. | Methods of treating neuropathic pain by modulation of glycogenolysis or glycolysis pathways |
| CN103626826B (zh) * | 2013-09-30 | 2015-10-21 | 承德医学院 | 含偶氮键的糖原磷酸化酶抑制剂胆酸类衍生物、其制备方法及医药用途 |
| CN103626825B (zh) * | 2013-09-30 | 2015-10-07 | 承德医学院 | 靶向肝脏的糖原磷酸化酶抑制剂胆酸类衍生物、其制备方法及医药用途 |
| CN103626837B (zh) * | 2013-09-30 | 2016-11-23 | 承德医学院 | 含生物可裂解二肽的糖原磷酸化酶抑制剂胆酸类衍生物、其制备方法及医药用途 |
| CN103819486B (zh) * | 2014-01-27 | 2016-08-17 | 承德医学院 | 标记血清糖原磷酸化酶浓度水平的光亲和标记探针分子、其制备方法及医药用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0021831D0 (en) * | 2000-09-06 | 2000-10-18 | Astrazeneca Ab | Chemical compounds |
| US7405210B2 (en) * | 2003-05-21 | 2008-07-29 | Osi Pharmaceuticals, Inc. | Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase |
| BRPI0410445B1 (pt) | 2003-05-21 | 2017-11-28 | Prosidion Limited | Pyrrolopyridine-2-carboxylic acid amide inhibitor compound of glycogen phosphorylase, pharmaceutical composition comprising the same, process for its production and intermediate compounds |
-
2005
- 2005-12-02 EP EP05815826A patent/EP1819704B1/en not_active Expired - Lifetime
- 2005-12-02 ES ES05815826T patent/ES2309822T3/es not_active Expired - Lifetime
- 2005-12-02 AT AT05815826T patent/ATE400574T1/de active
- 2005-12-02 JP JP2007543935A patent/JP2008521874A/ja not_active Withdrawn
- 2005-12-02 DK DK05815826T patent/DK1819704T3/da active
- 2005-12-02 DE DE602005008099T patent/DE602005008099D1/de not_active Expired - Lifetime
- 2005-12-02 PL PL05815826T patent/PL1819704T3/pl unknown
- 2005-12-02 US US11/792,183 patent/US8664397B2/en not_active Expired - Fee Related
- 2005-12-02 WO PCT/GB2005/050234 patent/WO2006059165A1/en not_active Ceased
- 2005-12-02 PT PT05815826T patent/PT1819704E/pt unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2661166C (en) | Compounds and methods for inhibiting the interaction of bcl proteins with binding partners | |
| EP2632551B1 (en) | Soluble guanylate cyclase activators | |
| WO2015085238A1 (en) | Inhibitors of lpxc | |
| CA3093851A1 (en) | Substituted 1,1'-biphenyl compounds, analogues thereof, and methods using same | |
| JP2006524222A5 (enExample) | ||
| JP2017128605A (ja) | 抗ウイルス化合物の固体形態 | |
| ES2966094T3 (es) | Compuestos 4-oxo-3,4-dihidrotieno[3,4-d]piridazina como inhibidores de la aldosa reductasa y métodos de uso de los mismos | |
| JP7759063B2 (ja) | プロドラッグ化合物、その製造方法、及び用途 | |
| TW201024313A (en) | Derivatives of 1-amino-2-cyclobutylethylboronic acid | |
| CA3081751A1 (en) | Substituted pyrrolopyrimidine jak inhibitors and methods of making and using the same | |
| JP2010510999A5 (enExample) | ||
| JP6592512B2 (ja) | 三環式アトロプ異性体の化合物 | |
| CN107105660A (zh) | 使用替唑尼特、其类似物或盐的前药的治疗组合物和治疗方法 | |
| BR112014003245B1 (pt) | Composto de ácido n-[5-(aminosulfonil)-4-metil-1,3-tiazol-2-il]-n-metil-2-[4-(2-piridinil)-fenil] acetamida metanossulfônico monohidratado cristalino, método para a sintetização do mesmo, e composição farmacêutica contendo o mesmo | |
| JP2009534358A5 (enExample) | ||
| EP4201934A1 (en) | N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide free base hemihydrate, methods of manufacture and uses thereof | |
| FR2943669A1 (fr) | Derives de nicotinamide,leur preparation et leur application en therapeutique | |
| JP2005526696A5 (enExample) | ||
| CA3143507A1 (en) | Small molecule target bromo/acetyl proteins and uses thereof | |
| JP2019526546A5 (enExample) | ||
| KR20170061616A (ko) | 피마살탄의 신규 염 | |
| JP2007527904A5 (enExample) | ||
| JP2010514734A5 (enExample) | ||
| WO2014146111A2 (en) | Analgesic compounds and methods of use | |
| JP2008521874A5 (enExample) |